2016.2.23 진행된 나피엠 23회 이은주(게스트) 발표자료입니다.

1. 국제공인프로젝트관리전문가
(PMP자격취득)
1
2015.02. 23

2. 국제공인프로젝트관리전문가
(PMP자격취득)
2
오늘의 주제
• 프로젝트가 금전적 가치를 목표로 하지 않을 경우, 어떠한
식으로 프로젝트를 평가하는지
• Project benefit: monetary vs. non-monetary

3. 국제공인프로젝트관리전문가
(PMP자격취득)
3
Project Monetary Value와 연관된 기존 방법 및 프로세스의 환기
• Earned value management
• Net present value
• Return on investment
• Cost benefit
• Cost avoidance
• Business case
• Prioritization among projects
• Project evaluation

4. 국제공인프로젝트관리전문가
(PMP자격취득)
4
Monetary Value 측정이 없는 경우의 문제
Monetary Value 측정이 어려운 경우
• 프로젝트의 규모
• BAU와의 중첩
• 안전, 복지, 인프라 등 경제적 가치와 같은 선에서 비교하기
힘든 project benefit
• 기타
비슷한 가치를 추구하는 non-monetary value 프로젝트들의 비교
평가
• 포트폴리오 안에서의 평가
• 최종 고객의 입장에서의 평가

5. 국제공인프로젝트관리전문가
(PMP자격취득)
5
Monetary value의 측정 불가시 중간 점검
Frequent questions in International Vaccine Institute
•How many lives can you save by delivering your
project?
•How many lives did you miss by not delivering
your project?
•How many lives did you miss by delaying your
project?

6. 국제공인프로젝트관리전문가
(PMP자격취득)
6
Why do we keep asking the questions?
질문의 목적은 Vision과 Mission을 확인하기 위해
Developing countries free of suffering from
infectious diseases
Discover, develop and deliver safe, effective and
affordable vaccines for developing nations

7. 국제공인프로젝트관리전문가
(PMP자격취득)
7
Introduction _ IVI
• International Organization
– UNDP initiative
– First International Organization in Korea
– 35 countries and WHO as state parties
• Global Vaccine Research Institute
– Lab facilities in Seoul
– Field programs in >20 countries: Asia,
Africa, Latin America
International Vaccine Institute

8. 국제공인프로젝트관리전문가
(PMP자격취득)
8
Introduction _ IVI
Major funders
– Bill & Melinda Gates Foundation
– Korean Government (Ministry of Education)
– Swedish Government (Sida)
Private- & public-sector and nonprofit donors
– Korea: Korea Support Committee for IVI (KSC), LG Electronics, Kia
Motors, Yanghyun Foundation, Korea Exchange Bank, Export Import
Bank of Korea, KOICA
– International: German Government (BMBF), UBS Optimus Foundation,
Thrasher Foundation, Rockefeller Foundation, Sanofi, Pfizer, GSK,
Merck

9. 국제공인프로젝트관리전문가
(PMP자격취득)
9
Introduction _ IVI
• Korea is IVI’s host country
• IVI bridges Korean partners and international partners in vaccines and
vaccination
• IVI helps fulfill Korea’s ODA contribution (as an OECD member) to
global health and international development and its contribution

10. 국제공인프로젝트관리전문가
(PMP자격취득)
10
IVI _ Unique Organization that performs all stages
• Pathogen genotyping
• Novel antigens
• Novel adjuvants
• New delivery
mechanisms
• New routes of
administration
• Laboratory process
development
• Assay development
• Technology transfer for
large-scale production
• Clinical trials
• Epidemiologic,
socioeconomic and socio-
behavioral studies
• Vaccine feasibility,
acceptance, and field
effectiveness studies
• Data synthesis (cost-
effectiveness and impact
analyses)
• Dissemination to
stakeholders

11. 국제공인프로젝트관리전문가
(PMP자격취득)
11
IVI _ How projects are evaluated
Impact
Disease Burden

12. 국제공인프로젝트관리전문가
(PMP자격취득)
12
IVI _ Technology to measure impact and burden
What technology is used to measure Impact and Disease
Burden
• Cost of Illness
• Willingness to Pay
• Burden of Disease
• Investment Case